TickerFacts.

QuidelOrtho Corp (QDEL): Share Repurchases

Annual figures by period end, from SEC filings.

$0
Year ended 2025-12-28
$103.50M2021-01-03: $43.70M2022-01-02: $103.50M2023-01-01: $74.30M2023-12-31: $7.20M2024-12-29: $02025-12-28: $0$0
2021-01-03 Share Repurchases (USD) 2025-12-28
Period endedShare RepurchasesChange YoYSource filing
2025-12-28$0n/a2026-02-19, From 2024-12-30
2024-12-29$0-100.0%2026-02-19, From 2024-01-01
2023-12-31$7.20M-90.3%2026-02-19, From 2023-01-02
2023-01-01, Fiscal 2022$74.30M-28.2%2025-02-27, From 2022-01-03
2022-01-02, Fiscal 2021$103.50M+136.8%2024-08-01, From 2021-01-04
2021-01-03, Fiscal 2020$43.70Mn/a2023-02-23, From 2019-12-30

Share Repurchases at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
QuidelOrtho Corp (QDEL)2025-12-28$0n/a
Idexx Laboratories Inc (IDXX)2025-12-31$1.22B+45.4%
Lantheus Holdings, Inc. (LNTH)2025-12-31$300.02M+200.0%
Volitionrx Ltd (VNRX)2024-12-31$0-100.0%

Compare QDEL, IDXX, LNTH, VNRX side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗